title: Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients.
authors.affiliation: Department of Surgery, Arizona Cancer Center, University of Arizona College of Medicine, 1501 North Campbell Avenue, Tucson, AZ 85724, USA. glato1@mindspring.com
authors.forename: Linda
authors.initials: L
authors.lastname: Meade-Tollin
authors.forename: Jesse D
authors.initials: JD
authors.lastname: Martinez
mesh_terms: D014408:Biomarkers, Tumor; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics*; D011379:Prognosis; D036104:Receptor, EphA2 / Q000096:biosynthesis*; D015854:Up-Regulation
chemical_list: D014408:Biomarkers, Tumor; D036104:Receptor, EphA2